Chembio Diagnostics Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Chembio Diagnostics are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Chembio Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong primary indicators, Chembio Diagnostics is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
Chembio |
Chembio Diagnostics Relative Risk vs. Return Landscape
If you would invest (100.00) in Chembio Diagnostics on October 18, 2025 and sell it today you would earn a total of 100.00 from holding Chembio Diagnostics or generate -100.0% return on investment over 90 days. Chembio Diagnostics is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Chembio, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Chembio Diagnostics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Chembio Diagnostics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Chembio Diagnostics, and traders can use it to determine the average amount a Chembio Diagnostics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CEMI |
Based on monthly moving average Chembio Diagnostics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chembio Diagnostics by adding Chembio Diagnostics to a well-diversified portfolio.
Chembio Diagnostics Fundamentals Growth
Chembio Stock prices reflect investors' perceptions of the future prospects and financial health of Chembio Diagnostics, and Chembio Diagnostics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Chembio Stock performance.
| Return On Equity | -0.89 | |||
| Return On Asset | -0.19 | |||
| Profit Margin | (0.47) % | |||
| Operating Margin | (0.41) % | |||
| Current Valuation | 16.42 M | |||
| Shares Outstanding | 36.73 M | |||
| Price To Earning | (8.49) X | |||
| Price To Book | 0.66 X | |||
| Price To Sales | 0.19 X | |||
| Revenue | 48.34 M | |||
| EBITDA | (14.61 M) | |||
| Cash And Equivalents | 22.84 M | |||
| Cash Per Share | 0.76 X | |||
| Total Debt | 10.2 K | |||
| Debt To Equity | 1.31 % | |||
| Book Value Per Share | 0.48 X | |||
| Cash Flow From Operations | (12.69 M) | |||
| Earnings Per Share | (0.71) X | |||
| Total Asset | 62.61 M | |||
| Retained Earnings | (73.47 M) | |||
| Current Asset | 12.63 M | |||
| Current Liabilities | 3.15 M | |||
Things to note about Chembio Diagnostics performance evaluation
Checking the ongoing alerts about Chembio Diagnostics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Chembio Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Chembio Diagnostics is not yet fully synchronised with the market data | |
| Chembio Diagnostics has some characteristics of a very speculative penny stock | |
| Chembio Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 48.34 M. Net Loss for the year was (23.29 M) with profit before overhead, payroll, taxes, and interest of 3.88 M. | |
| Chembio Diagnostics currently holds about 22.84 M in cash with (12.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.76. |
- Analyzing Chembio Diagnostics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Chembio Diagnostics' stock is overvalued or undervalued compared to its peers.
- Examining Chembio Diagnostics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Chembio Diagnostics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Chembio Diagnostics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Chembio Diagnostics' stock. These opinions can provide insight into Chembio Diagnostics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Chembio Stock
If you are still planning to invest in Chembio Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Chembio Diagnostics' history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |